Skip to main content
. 2015 Mar 5;16(8):853–862. doi: 10.1093/ehjci/jeu314

Figure 2.

Figure 2

(A) Males: event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) with follow-up extending to 5 years stratified by coronary dominance in patients with obstructive CAD (>50%) on CCTA. (B) Females: event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) with follow-up extending to 5 years stratified by coronary dominance in patients with obstructive CAD (>50%) on CCTA. Patients with a balanced coronary artery system were excluded from the analysis.